Unjha Formulations Limited (BOM:531762)
India · Delayed Price · Currency is INR 20.25
+1.05 (5.47%)
At close: Jul 8, 2026
Unjha Formulations Market Cap
Unjha Formulations has a market cap or net worth of 90.73 million as of July 8, 2026. Its market cap has decreased by -10.52% in one year.
Market Cap
90.73M
Enterprise Value
74.28M
Revenue
157.49M
Ranking
n/a
PE Ratio
12.90
Stock Price
20.25
Market Cap Chart
Since May 25, 2005, Unjha Formulations's market cap has increased from 51.62M to 90.73M, an increase of 75.78%. That is a compound annual growth rate of 2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 90.73M | -19.00% |
| Dec 31, 2025 | 112.01M | -17.68% |
| Dec 31, 2024 | 136.07M | 86.43% |
| Dec 29, 2023 | 72.99M | 6.19% |
| Dec 30, 2022 | 68.73M | 42.04% |
| Dec 31, 2021 | 48.39M | 19.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenith Healthcare | 163.90M |
| Norris Medicines | 147.61M |
| Ortin Global | 135.55M |
| Shamrock Industrial Company | 127.82M |
| Emmessar Biotech & Nutrition | 122.25M |
| Beryl Drugs | 107.62M |
| Vivanza Biosciences | 76.00M |
| Ganga Pharmaceuticals | 70.94M |